Back to company

INNOMED INNOVATION MEDICAL ApS: Financial statements 2022

CVR: 25139356

INNOMED INNOVATION MEDICAL ApS (CVR 25139356) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 179,774 and a net result of DKK -41,296 compared with DKK 4,298 the year before. That is a decrease of 25% compared with the year before. Equity amounted to DKK 181,181. The solvency ratio was 15.7%. The company had 2 employees in the financial year.

Gross Profit
179,774 kr.
Profit/Loss
-41,296 kr.
Equity
181,181 kr.
Total Assets
1,157,050 kr.
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-180 t.-41 t.181 t.2
2021-240 t.4 t.222 t.2
2020-420 t.158 t.218 t.2
2019-474 t.196 t.520 t.3
2018-73 t.308 t.767 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on INNOMED INNOVATION MEDICAL ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

INNOMED INNOVATION MEDICAL ApS: The 2021 annual report is outJun 2, 2022

INNOMED INNOVATION MEDICAL ApS has published its annual report for 2021. Gross profit came to DKK 239,654, and the net result was DKK 4,298.

About INNOMED INNOVATION MEDICAL ApS

INNOMED INNOVATION MEDICAL ApS is a Danish company of the type Anpartsselskab based in Hirtshals, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens Kjeldgaard. The company is owned by Jens Kjeldgaard. The company has 3 employees. In 2025, the company reported a gross profit of DKK 248,225 and a net result of DKK 41,979 compared with DKK 64,825 the year before. Equity amounted to DKK 385,198.